Innocoll Holdings PLC (INNL) Given Coverage Optimism Rating of 0.02
News headlines about Innocoll Holdings PLC (NASDAQ:INNL) have been trending somewhat positive this week, according to Accern Sentiment Analysis. The research firm ranks the sentiment of media coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Innocoll Holdings PLC earned a media sentiment score of 0.02 on Accern’s scale. Accern also assigned news headlines about the specialty pharmaceutical company an impact score of 46.9092103377851 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Separately, FBR & Co reiterated a “hold” rating on shares of Innocoll Holdings PLC in a research note on Tuesday, July 4th.
Shares of Innocoll Holdings PLC (INNL) opened at 2.35 on Friday. The company’s 50 day moving average is $2.25 and its 200-day moving average is $1.58. Innocoll Holdings PLC has a 52 week low of $0.53 and a 52 week high of $6.51.
Innocoll Holdings PLC Company Profile
Innocoll Holdings Public Limited Company is a commercial-stage specialty pharmaceutical and medical device company with late-stage development programs. The Company operates through the segment of manufacture and sale of collagen-based pharmaceutical products. It utilizes collagen-based technology platform to develop its biodegradable and bioresorbable products and product candidates, which can be broken down by the body without the need for surgical removal or applied topically.
Receive News & Stock Ratings for Innocoll Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innocoll Holdings PLC and related stocks with our FREE daily email newsletter.